NOS3 and inflammatory bowel disease: IBD patients exhibit increased activity of arginase, an enzyme that competes with endothelial nitric oxide synthase (eNOS) for the common substrate L-arginine, thereby reducing the bioavailability of L-arginine for NO production [95,96,97].